Volume 27, Issue 6 e12912
ORIGINAL ARTICLE

Cognitive deficits and psychopathological symptoms among children with medulloblastoma

Annamária Szentes

Corresponding Author

Annamária Szentes

2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary

Correspondence

Annamária Szentes, 2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary.

Email: [email protected]

Search for more papers by this author
Nikoletta Erős

Nikoletta Erős

2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary

Search for more papers by this author
Zoltán Kekecs

Zoltán Kekecs

Department of Psychology, Lund University, Lund, Sweden

Search for more papers by this author
Zsuzsanna Jakab

Zsuzsanna Jakab

2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary

Search for more papers by this author
Szabolcs Török

Szabolcs Török

Institute of Mental Health, Semmelweis University, Budapest, Hungary

Search for more papers by this author
Dezső Schuler

Dezső Schuler

2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary

Search for more papers by this author
Péter Hauser

Péter Hauser

2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary

Authors are equally contributed as last or senior authors.Search for more papers by this author
Miklós Garami

Miklós Garami

2nd Department of Pediatrics, Semmelweis University, Budapest, Hungary

Authors are equally contributed as last or senior authors.Search for more papers by this author
First published: 11 September 2018
Citations: 19

Abstract

Children with medulloblastoma (MB) are predisposed for negative cognitive sequela, which has been widely identified in this population. The purpose of the present study was to explore cognitive deficits and psychopathological symptoms and analyse their relation among MB survivors. The Wechsler Intelligence Scale for Children and the Mini International Neuropsychiatric Interview (MINI-KID) was administered to 34 MB survivors to measure cognitive functioning and psychopathological symptoms. The MB survivors had lower global IQ (86.41 [79.70–93.13]) compared with the control population mean. We found impaired functioning in all IQ subscales in the MB survivors group, of which processing speed (84.15 [77.71–90.58]) was the most affected. Higher radiation dose and high-dose chemotherapy with stem cell rescue were significantly associated factors for lowered global IQ, while age at diagnosis, sex and time period from diagnosis were not significantly associated. Compulsive disorder, generalised anxiety, separation anxiety and posttraumatic stress disorder were significantly more prevalent in the MB survivor group than a group of 46 control participants. No correlation was found between the cognitive deficits and the psychopathological symptoms. Our results identify that MB survivors suffer from cognitive and psychopathological impairments, and these could exist independently from each other.

CONFLICT OF INTEREST

The authors declare that they have no conflict of interests.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.